We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$463M
AUM Growth
+$88.4M
Cap. Flow
+$76.3M
Cap. Flow %
16.48%
Top 10 Hldgs %
15.82%
Holding
310
New
106
Increased
69
Reduced
87
Closed
41

Top Buys

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$5.74M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$5.51M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.03M
4
IMPV
Imperva, Inc.
IMPV
+$4.56M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$2.3M

Top Sells

Rank Stock Value
1
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
+$4.9M
2
TSCO icon
Tractor Supply
TSCO
+$4.44M
3
LPNT
LifePoint Health, Inc.
LPNT
+$3.96M
4
WCC
WESCO International
WCC
+$3.55M
5
IDTI
Integrated Device Technology I
IDTI
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Technology 14.58%
3 Industrials 10.71%
4 Consumer Staples 7.92%
5 Materials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CE icon
126
Celanese
CE
$5.09B
$782K 0.17%
7,304
+144
+2% +$15.3K
NDAQ icon
127
Nasdaq
NDAQ
$51.5B
$780K 0.17%
30,441
+606
+2% +$15.3K
PF
128
DELISTED
Pinnacle Foods, Inc.
PF
$780K 0.17%
13,120
-436
-3% -$24.6K
IEFA icon
129
iShares Core MSCI EAFE ETF
IEFA
$186B
$768K 0.17%
11,620
-534
-4% -$34.8K
GXP
130
DELISTED
Great Plains Energy Incorporated
GXP
$765K 0.17%
23,734
-247
-1% -$8.12K
VLO icon
131
Valero Energy
VLO
$89.8B
$759K 0.16%
8,263
+181
+2% +$14.9K
AKAO
132
DELISTED
Achaogen Inc
AKAO
$751K 0.16%
+69,889
New +$877K
MPC icon
133
Marathon Petroleum
MPC
$90.3B
$744K 0.16%
11,281
-350
-3% -$21.4K
PX
134
DELISTED
Praxair Inc
PX
$739K 0.16%
+4,777
New +$709K
HDP
135
DELISTED
Hortonworks, Inc.
HDP
$734K 0.16%
+36,483
New +$669K
MDT icon
136
Medtronic
MDT
$107B
$733K 0.16%
9,077
-24
-0.3% -$1.92K
EMN icon
137
Eastman Chemical
EMN
$7.8B
$732K 0.16%
7,899
-112
-1% -$10.2K
HXL icon
138
Hexcel
HXL
$8.32B
$732K 0.16%
11,842
+65
+0.6% +$3.95K
ALB icon
139
Albemarle
ALB
$13.5B
$729K 0.16%
+5,699
New +$773K
DCI icon
140
Donaldson
DCI
$10.8B
$726K 0.16%
+14,840
New +$707K
UNM icon
141
Unum
UNM
$13.8B
$725K 0.16%
13,204
-302
-2% -$16.2K
EXLS icon
142
EXL Service
EXLS
$4.23B
$717K 0.15%
59,395
-2,440
-4% -$29.8K
IBM icon
143
IBM
IBM
$202B
$697K 0.15%
4,752
-89
-2% -$12.9K
MTB icon
144
M&T Bank
MTB
$36.2B
$694K 0.15%
4,056
+259
+7% +$43K
OXFD
145
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$692K 0.15%
+49,514
New +$725K
GPK icon
146
Graphic Packaging
GPK
$3.26B
$690K 0.15%
44,649
-394
-0.9% -$5.93K
INBK icon
147
First Internet Bancorp
INBK
$231M
$687K 0.15%
17,998
-468
-3% -$17.5K
MXIM
148
DELISTED
Maxim Integrated Products
MXIM
$680K 0.15%
12,998
+304
+2% +$15.8K
DFS
149
DELISTED
Discover Financial Services
DFS
$667K 0.14%
8,672
-4
-0% -$275
VSEC icon
150
VSE Corp
VSEC
$5.48B
$666K 0.14%
+13,754
New +$705K
4 5
6
7 8

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2017 Portfolio in Review

As of Q4 2017, Stanley-Laman Group held 310 positions worth $463M, up 24% from $375M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group deployed $76.3M of net new capital in Q4 2017, opening 106 new positions and adding to 69 existing holdings. Its largest new stake was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was JBT Marel, an estimated $889K trimmed.

  • Stanley-Laman Group's largest Q4 2017 buy was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.
  • Stanley-Laman Group added most to Proofpoint, Inc. in Q4 2017, an estimated $5.74M increase.
  • Stanley-Laman Group's biggest Q4 2017 reduction was JBT Marel, cutting an estimated $889K.
  • Stanley-Laman Group fully exited Tenneco Inc. Class A Voting Common Stock in Q4 2017, selling an estimated $4.9M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $463M portfolio in Q4 2017.
  • Stanley-Laman Group opened 106 new positions and closed 41 in Q4 2017.
  • Stanley-Laman Group's portfolio value rose 24% quarter-over-quarter to $463M.

Based on Stanley-Laman Group's 13F filing for Q4 2017, filed 9 Feb 2018.